MERCK SHARP & DOHME LLCSEC Filings
|
|
All SEC filings by MERCK SHARP & DOHME LLC — annual and quarterly reports, current reports, registrations, proxies and ownership forms, updated in real time.
Financials
| ARS | Annual report to shareholders | Apr 13, 2012 | ||
| 10-K | Annual report | View Diff | Mar 30, 2010 | |
| 10-Q | Quarterly report | View Diff | Nov 2, 2009 | |
| 10-Q | Quarterly report | View Diff | Aug 3, 2009 | |
| 10-Q | Quarterly report | View Diff | May 4, 2009 | |
| ARS | Annual report to shareholders | Mar 17, 2009 | ||
| 10-K | Annual report | View Diff | Feb 27, 2009 | |
| 10-Q | Quarterly report | View Diff | Nov 3, 2008 | |
| 10-Q | Quarterly report | View Diff | Jul 31, 2008 | |
| 10-Q | Quarterly report | View Diff | May 5, 2008 |
Events
| 8-K | Entry Into a Material Definitive Agreement | Nov 4, 2009 | ||
| 8-K | Merck Announces Third-Quarter 2009 Financial Results | Oct 22, 2009 | ||
| 8-K | Termination of a Material Definitive Agreement | Sep 21, 2009 | ||
| 8-K | Entry Into a Material Definitive Agreement | Jul 31, 2009 | ||
| 8-K | Merck Announces Second-Quarter 2009 Financial Results | Jul 21, 2009 | ||
| 8-K | Other Events | Jul 1, 2009 | ||
| 8-K | Other Events | Jun 25, 2009 | ||
| 8-K | Other Events | Jun 22, 2009 | ||
| 8-K | Other Events | May 20, 2009 | ||
| 8-K | Entry Into a Material Definitive Agreement | May 12, 2009 |
Registrations and Prospectuses
| SC TO-C | Information about tender offer | Mar 25, 2026 | ||
| SC TO-C | Information about tender offer | Mar 25, 2026 | ||
| SC TO-C | Information about tender offer | Mar 25, 2026 | ||
| SC TO-C | Information about tender offer | Nov 14, 2025 | ||
| SC TO-T/A | Third party tender offer statement | Jan 11, 2023 | ||
| SC TO-T/A | Third party tender offer statement | Dec 21, 2022 | ||
| SC TO-T | Third party tender offer statement | Dec 12, 2022 | ||
| SC TO-C | Information about tender offer | Nov 21, 2022 | ||
| SC TO-T/A | Third party tender offer statement | Nov 22, 2021 | ||
| SC TO-T/A | Third party tender offer statement | Nov 17, 2021 |
Proxies
| DFAN14A | Additional proxy materials by non-management | Sep 10, 2025 | ||
| DFAN14A | Additional proxy materials by non-management | Jul 30, 2025 | ||
| DFAN14A | Additional proxy materials by non-management | Jul 9, 2025 | ||
| DFAN14A | Additional proxy materials by non-management | Jul 9, 2025 | ||
| DFAN14A | Additional proxy materials by non-management | Jul 9, 2025 | ||
| DFAN14A | Additional proxy materials by non-management | Jan 10, 2024 | ||
| DFAN14A | Additional proxy materials by non-management | Jan 8, 2024 | ||
| DEFA14A | Additional proxy soliciting materials | Aug 3, 2009 | ||
| DEFA14A | Additional proxy soliciting materials | Jul 30, 2009 | ||
| DEFA14A | Additional proxy soliciting materials | Jul 24, 2009 |
Other
| NO ACT | No action letter | Feb 10, 2011 | ||
| NO ACT | No action letter | Mar 29, 2010 | ||
| NO ACT | No action letter | Mar 29, 2010 | ||
| EFFECT | Notice of effectiveness | Nov 9, 2009 | ||
| UPLOAD | Letter from SEC | Oct 14, 2009 | ||
| CORRESP | Correspondence with SEC | Oct 1, 2009 | ||
| UPLOAD | Letter from SEC | Sep 28, 2009 | ||
| CORRESP | Correspondence with SEC | Jul 2, 2009 | ||
| NO ACT | No action letter | Feb 3, 2009 | ||
| CT ORDER | Confidential treatment order | Aug 27, 2008 |
Ownership
| 13F-NT | Notice of holdings reported by another manager | Aug 7, 2026 | ||
| 13F-NT | Notice of holdings reported by another manager | May 13, 2026 | ||
| 13F-NT | Notice of holdings reported by another manager | Feb 17, 2026 | ||
| 13F-NT | Notice of holdings reported by another manager | Nov 12, 2025 | ||
| 13F-NT | Notice of holdings reported by another manager | Aug 13, 2025 | ||
| 13F-NT | Notice of holdings reported by another manager | May 14, 2025 | ||
| 13F-NT | Notice of holdings reported by another manager | Feb 14, 2025 | ||
| 3 | Merck & Co., Inc. | Dec 23, 2024 | ||
| 4 | Merck & Co., Inc. | Mar 11, 2024 | ||
| SC 13D/A | Harpoon Therapeutics, Inc. | Mar 11, 2024 |